-
1
-
-
0023972830
-
Acarbose, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential
-
Clissold SP, Edwards C. Acarbose, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 35:1988;214-243.
-
(1988)
Drugs.
, vol.35
, pp. 214-243
-
-
Clissold, S.P.1
Edwards, C.2
-
2
-
-
0029133235
-
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
-
Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. NEJM. 333:1995;550-554.
-
(1995)
NEJM.
, vol.333
, pp. 550-554
-
-
Stumvoll, M.1
Nurjhan, N.2
Perriello, G.3
-
3
-
-
0025823825
-
Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone
-
Hanefeld M, Fischer S, Schulze J, et al. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care. 14:1991;732-737.
-
(1991)
Diabetes Care.
, vol.14
, pp. 732-737
-
-
Hanefeld, M.1
Fischer, S.2
Schulze, J.3
-
4
-
-
0028357199
-
Efficacy of 24-week monotherapy with acarbose, glibenclamide or placebo in NIDDM patients. The Essen Study
-
Hoffmann J, Spengler M. Efficacy of 24-week monotherapy with acarbose, glibenclamide or placebo in NIDDM patients. The Essen Study. Diabetes Care. 17:1994;561-566.
-
(1994)
Diabetes Care.
, vol.17
, pp. 561-566
-
-
Hoffmann, J.1
Spengler, M.2
-
5
-
-
0027947449
-
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus
-
Chiasson J-L, Josse RG, Hunt JA, et al. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. Ann Intern Med. 121:1994;928-935.
-
(1994)
Ann Intern Med.
, vol.121
, pp. 928-935
-
-
Chiasson J-L1
Josse, R.G.2
Hunt, J.A.3
-
6
-
-
0029064970
-
Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus
-
Coniff RF, Shapiro JA, Seaton TB, Bray GA. Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. Am J Med. 98:1995;443-451.
-
(1995)
Am J Med.
, vol.98
, pp. 443-451
-
-
Coniff, R.F.1
Shapiro, J.A.2
Seaton, T.B.3
Bray, G.A.4
-
7
-
-
0029044690
-
Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study
-
Coniff RF, Shapiro JA, Robbins D, et al. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study. Diabetes Care. 18:1995;817-824.
-
(1995)
Diabetes Care.
, vol.18
, pp. 817-824
-
-
Coniff, R.F.1
Shapiro, J.A.2
Robbins, D.3
-
8
-
-
0027935577
-
Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study
-
Hermann LS, Scherstén B, Bitzén P-O, et al. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care. 17:1994;1100-1109.
-
(1994)
Diabetes Care.
, vol.17
, pp. 1100-1109
-
-
Hermann, L.S.1
Scherstén, B.2
Bitzén P-O3
-
9
-
-
0029099086
-
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
-
DeFronzo RA, Goodmann AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. NEJM. 333:1995;541-549.
-
(1995)
NEJM.
, vol.333
, pp. 541-549
-
-
Defronzo, R.A.1
Goodmann, A.M.2
-
10
-
-
0029587420
-
The use of acarbose in the primary-care setting: Evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study
-
Spengler M, Cagatay M. The use of acarbose in the primary-care setting: evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study. Clin Invest Med. 18:1995;325-331.
-
(1995)
Clin Invest Med.
, vol.18
, pp. 325-331
-
-
Spengler, M.1
Cagatay, M.2
-
11
-
-
0345284828
-
Comparison of acarbose and metformin treatment in non-insulin-dependent diabetic out-patients
-
W. Creutzfeld. Amsterdam: Excerpta Medica
-
Schwedes U, Petzoldt R, Hillebrand I, Schöffling K. Comparison of acarbose and metformin treatment in non-insulin-dependent diabetic out-patients. Creutzfeld W. First International Symposium on Acarbose. 1982;275-281 Excerpta Medica, Amsterdam.
-
(1982)
First International Symposium on Acarbose
, pp. 275-281
-
-
Schwedes, U.1
Petzoldt, R.2
Hillebrand, I.3
Schöffling, K.4
-
12
-
-
0030070954
-
A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients
-
Bayraktar M, Adalar N, Van Thiel DH. A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients. Diabetes Care. 19:1996;252-254.
-
(1996)
Diabetes Care.
, vol.19
, pp. 252-254
-
-
Bayraktar, M.1
Adalar, N.2
Van Thiel, D.H.3
-
13
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra centrifuge
-
Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra centrifuge. Clin Chem. 18:1972;499-502.
-
(1972)
Clin Chem.
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Frederickson, D.S.3
-
15
-
-
0003312934
-
Non-insulin-dependent Diabetes Mellitus (NIDDM)
-
Sydney: Health Communication Australia Pty Limited
-
Baba S, Zimmet P. Non-insulin-dependent Diabetes Mellitus (NIDDM). Practical Targets and Treatments. 1995;Health Communication Australia Pty Limited, Sydney.
-
(1995)
Practical Targets and Treatments
-
-
Baba, S.1
Zimmet, P.2
-
16
-
-
0028874605
-
Consensus statement: The pharmacological treatment of hyperglycemia in NIDDM
-
Consensus statement: The pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care. 18:1995;1510-1518.
-
(1995)
Diabetes Care.
, vol.18
, pp. 1510-1518
-
-
-
17
-
-
0024519649
-
Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes
-
Hother-Nielsen O, Schmitz O, Andersen PH. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol. 120:1989;257-265.
-
(1989)
Acta Endocrinol.
, vol.120
, pp. 257-265
-
-
Hother-Nielsen, O.1
Schmitz, O.2
Andersen, P.H.3
-
18
-
-
0345716476
-
Metformin improves insulin sensitivity in insulin-resistant normoglycemic relatives of patients with non-insulin-dependent diabetes mellitus
-
Eriksson J, Widén E, Saloranta C. Metformin improves insulin sensitivity in insulin-resistant normoglycemic relatives of patients with non-insulin-dependent diabetes mellitus. Diabetes. 39:(suppl 1):1990;109A.
-
(1990)
Diabetes.
, vol.39
, Issue.SUPPL. 1
-
-
Eriksson, J.1
Widén, E.2
Saloranta, C.3
-
19
-
-
0027495982
-
The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients
-
Johnson AB, Webster JM, Sum C-F, et al. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism. 42:1993;1217-1222.
-
(1993)
Metabolism
, vol.42
, pp. 1217-1222
-
-
Johnson, A.B.1
Webster, J.M.2
Sum C-F3
-
20
-
-
0027399661
-
Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects
-
Nagi DK, Yudkin JS. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. Diabetes Care. 16:1993;621-629.
-
(1993)
Diabetes Care.
, vol.16
, pp. 621-629
-
-
Nagi, D.K.1
Yudkin, J.S.2
-
21
-
-
0344853459
-
Can we prevent the development of non-insulin-dependent diabetes mellitus?
-
Chiasson J-L, Josse RG, Leiter LA, et al. Can we prevent the development of non-insulin-dependent diabetes mellitus? Diabetes. 43:(suppl 1):1994;62A.
-
(1994)
Diabetes.
, vol.43
, Issue.SUPPL. 1
-
-
Chiasson J-L1
Josse, R.G.2
Leiter, L.A.3
-
22
-
-
0025780331
-
Hyperinsulinemia: The key feature of a cardiovascular and metabolic syndrome
-
Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34:1991;416-422.
-
(1991)
Diabetologia.
, vol.34
, pp. 416-422
-
-
Ferrannini, E.1
Haffner, S.M.2
Mitchell, B.D.3
Stern, M.P.4
-
23
-
-
0025790941
-
Insulin and cardiovascular disease. Paris Prospective Study
-
Fontbonne AM, Eschwège EM. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 14:1991;461-469.
-
(1991)
Diabetes Care.
, vol.14
, pp. 461-469
-
-
Fontbonne, A.M.1
Eschwège, E.M.2
-
24
-
-
0027250501
-
Risk factors for early death in non-insulin-dependent diabetes and men with known glucose tolerance status
-
Balkau B, Eschwège E, Papoz L, et al. Risk factors for early death in non-insulin-dependent diabetes and men with known glucose tolerance status. BMJ. 307:1993;295-299.
-
(1993)
BMJ.
, vol.307
, pp. 295-299
-
-
Balkau, B.1
Eschwège, E.2
Papoz, L.3
-
25
-
-
0027458051
-
Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: Errors of metabolism or methods?
-
Groop LC, Widén E E, Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or methods? Diabetologia. 36:1993;1326-1331.
-
(1993)
Diabetologia.
, vol.36
, pp. 1326-1331
-
-
Groop, L.C.1
Widén, E.E.2
Ferrannini, E.3
-
26
-
-
0027180306
-
Insulin and atherosclerosis: Villain, accomplice, or innocent bystander?
-
Savage PJ. Insulin and atherosclerosis: villain, accomplice, or innocent bystander? Br Heart J. 69:1993;473-475.
-
(1993)
Br Heart J.
, vol.69
, pp. 473-475
-
-
Savage, P.J.1
-
27
-
-
0027968932
-
Why is insulin not a risk factor for coronary heart disease?
-
Jarrett RJ. Why is insulin not a risk factor for coronary heart disease? Diabetologia. 37:1994;945-947.
-
(1994)
Diabetologia.
, vol.37
, pp. 945-947
-
-
Jarrett, R.J.1
-
28
-
-
0029363997
-
Associations between insulin levels and cardiovascular disease are confounded by comorbidity
-
McKeigue P, Davey G. Associations between insulin levels and cardiovascular disease are confounded by comorbidity. Diabetes Care. 18:1995;1294-1298.
-
(1995)
Diabetes Care.
, vol.18
, pp. 1294-1298
-
-
McKeigue, P.1
Davey, G.2
-
30
-
-
0030025673
-
Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system
-
Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system. NEJM. 334:1996;374-381.
-
(1996)
NEJM.
, vol.334
, pp. 374-381
-
-
Reaven, G.M.1
Lithell, H.2
Landsberg, L.3
-
31
-
-
0345716475
-
Chronic hyperinsulinemia is a cause of insulin resistance for both glucose and protein metabolism
-
Battezzati A, Teruzzi I, Perseghin G, et al. Chronic hyperinsulinemia is a cause of insulin resistance for both glucose and protein metabolism. Horm Metab Res. 27:1995;60.
-
(1995)
Horm Metab Res.
, vol.27
, pp. 60
-
-
Battezzati, A.1
Teruzzi, I.2
Perseghin, G.3
-
32
-
-
0030027671
-
Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study
-
Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation. 93:1996;54-59.
-
(1996)
Circulation.
, vol.93
, pp. 54-59
-
-
Bao, W.1
Srinivasan, S.R.2
Berenson, G.S.3
-
33
-
-
0027370108
-
The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM. 329:1993;977-986.
-
(1993)
NEJM.
, vol.329
, pp. 977-986
-
-
-
34
-
-
0028817815
-
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease
-
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes. 44:1995;1249-1258.
-
(1995)
Diabetes.
, vol.44
, pp. 1249-1258
-
-
-
35
-
-
0001173389
-
Clinical pharmacology of biguanides
-
J. Kuhlmann, Puls W. Berlin: Springer
-
Hermann LS. Clinical pharmacology of biguanides. Kuhlmann J, Puls W. Handbook of Experimental Pharmacology. 119:1996;373-407 Springer, Berlin.
-
(1996)
Handbook of Experimental Pharmacology
, vol.119
, pp. 373-407
-
-
Hermann, L.S.1
-
36
-
-
0026754428
-
Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
-
Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol. 70:1992;733-737.
-
(1992)
Am J Cardiol.
, vol.70
, pp. 733-737
-
-
Assmann, G.1
Schulte, H.2
-
37
-
-
0027939375
-
Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis
-
Drexel H, Amann FW, Beran J, et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation. 90:1994;2230-2235.
-
(1994)
Circulation.
, vol.90
, pp. 2230-2235
-
-
Drexel, H.1
Amann, F.W.2
Beran, J.3
-
38
-
-
0025878878
-
Beneficial effects on serum lipids in non-insulin-dependent diabetics by acarbose treatment
-
Leonhardt W, Hanefeld M, Fischer S, et al. Beneficial effects on serum lipids in non-insulin-dependent diabetics by acarbose treatment. Drug Res. 41:1991;735-738.
-
(1991)
Drug Res.
, vol.41
, pp. 735-738
-
-
Leonhardt, W.1
Hanefeld, M.2
Fischer, S.3
-
39
-
-
0001540692
-
Efficacy of acarbose in hyperinsulinemia and hyperlipidemia of obesity
-
Maruhama Y, Sasaki M, Ninomiya K, et al. Efficacy of acarbose in hyperinsulinemia and hyperlipidemia of obesity. Clin Rep (Japan). 29:1995;173-180.
-
(1995)
Clin Rep (Japan).
, vol.29
, pp. 173-180
-
-
Maruhama, Y.1
Sasaki, M.2
Ninomiya, K.3
-
40
-
-
0345284826
-
Clinical studies on the parameters of lipid metabolism in patients with different types of diabetes mellitus
-
W. Creutzfeld. Amsterdam: Excerpta Medica
-
Marx W, Thomsen P, Ravens K-G. Clinical studies on the parameters of lipid metabolism in patients with different types of diabetes mellitus. Creutzfeld W. First International Symposium on Acarbose. 1982;380-384 Excerpta Medica, Amsterdam.
-
(1982)
First International Symposium on Acarbose
, pp. 380-384
-
-
Marx, W.1
Thomsen, P.2
Ravens K-G3
-
41
-
-
0020354048
-
A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type 2 (non-insulin-dependent) diabetes
-
Taylor KG, John WG, Mathews KA, Wright AD. A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type 2 (non-insulin-dependent) diabetes. Diabetologia. 23:1982;507-510.
-
(1982)
Diabetologia.
, vol.23
, pp. 507-510
-
-
Taylor, K.G.1
John, W.G.2
Mathews, K.A.3
Wright, A.D.4
-
42
-
-
0025313775
-
Comparison of tolbutamide and metformin in elderly diabetic patients
-
Josephkutty S, Potter JM. Comparison of tolbutamide and metformin in elderly diabetic patients. Diabet Med. 7:1990;510-514.
-
(1990)
Diabet Med.
, vol.7
, pp. 510-514
-
-
Josephkutty, S.1
Potter, J.M.2
-
43
-
-
0025903612
-
Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD
-
Noury J, Nandeuil A. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD. Diabet Metab. 17:1991;209-212.
-
(1991)
Diabet Metab.
, vol.17
, pp. 209-212
-
-
Noury, J.1
Nandeuil, A.2
-
44
-
-
0025873686
-
Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles
-
Hermann LS, Karlsson J-E, Sjöstrand É. Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles. Eur J Clin Pharmacol. 41:1991;263-265.
-
(1991)
Eur J Clin Pharmacol.
, vol.41
, pp. 263-265
-
-
Hermann, L.S.1
Karlsson J-E2
Sjöstrand, É.3
-
45
-
-
0028605970
-
One year comparative trial of metformin and glipizide in type 2 diabetes mellitus
-
Campbell IW, Menzies DG, Chalmers J, et al. One year comparative trial of metformin and glipizide in type 2 diabetes mellitus. Diabete Metab. 21:1994;394-400.
-
(1994)
Diabete Metab.
, vol.21
, pp. 394-400
-
-
Campbell, I.W.1
Menzies, D.G.2
Chalmers, J.3
-
46
-
-
0028798236
-
Wirksamkeit und Verträglichkeit von einschleichend dosierter Acarbose bei Patienten mit einem nicht insulinpflichtigen Diabetes mellitus (NIDDM) unter Sulfonylharnstofftherapie
-
May C. Wirksamkeit und Verträglichkeit von einschleichend dosierter Acarbose bei Patienten mit einem nicht insulinpflichtigen Diabetes mellitus (NIDDM) unter Sulfonylharnstofftherapie. Diabetes Stoffw. 4:1995;3-8.
-
(1995)
Diabetes Stoffw.
, vol.4
, pp. 3-8
-
-
May, C.1
|